TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

Teva

CardiovascularDermatologyOncology
Generics

Teva is a generic drug manufacturer focused on Cardiovascular, Dermatology, Oncology. Key products include MICAFUNGIN.

1948
Since
764
Drugs
-
Trials
5306
Approved (2yr)

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 30%
48 drugs
Dermatology 19%
27 drugs Phase 3: 6
Oncology 17%
27 drugs Phase 1: 6
Neurology 17%
21 drugs Phase 3: 8 Phase 2: 1 Phase 1: 3
Infectious Disease 16%
26 drugs Phase 2: 1 Phase 1: 1

Pipeline Strength Pro

Loading...